Literature DB >> 23220220

Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.

C Kliwinski1, P R Cooper, R Perkinson, J R Mabus, S H Tam, T M Wilkinson, J Giles-Komar, B Scallon, G D Powers, P J Hornby.   

Abstract

Immunoglobulin G (IgG) is transcytosed across intestinal epithelial cells of suckling mammals by the neonatal Fc receptor (FcRn); however, the contribution of FcRn vs. FcRn-independent uptake to serum IgG levels had not been determined in either rat pups or human (h)FcRn-expressing mice (Tg276 and Tg32). In isoflurane-anesthetized rodents, serum levels were determined after regional intestinal delivery of human monoclonal antibodies (hIgG) with either wild-type (WT) Fc sequences or variants engineered for different FcRn binding affinities. Detection of full-length hIgG was by immunoassay; intestinal hFcRn and hIgG localization was by immunocytochemistry. High (μg/ml) serum levels of hIgG were detected after proximal intestinal delivery (0.1-10 mg/kg) in 2-wk-old rats. Human FcRn was visualized in epithelial cells of Tg276 mice, but low serum hIgG levels (<10 ng/ml) were obtained. In rat pups, intraintestinal hIgG1 WT administration resulted in dose-related and saturable uptake, whereas uptake of a low FcRn-binding affinity variant was nonsaturable. There were no differences in hIgG levels from systemic and hepatic portal vein serum samples, and intense hIgG immunostaining was noted in villi enterocytes and within lymphatic lacteal-like vessels. This study demonstrated that FcRn-mediated uptake in rat pups accounted for ~80% of serum hIgG levels and that IgG enters the circulation via the lymph and not the hepatic portal vein. The remaining uptake though the immature intestine is nonreceptor mediated. Intestinal epithelial cell hFcRn expression occurred in Tg276 mice, but receptor-mediated transport of IgG was not observed. The suckling rat pup intestine is a mechanistic model of FcRn-IgG-mediated transcytosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220220     DOI: 10.1152/ajpgi.00340.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  12 in total

Review 1.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

2.  Localization of the human neonatal Fc receptor (FcRn) in human nasal epithelium.

Authors:  Sara Heidl; Isabella Ellinger; Verena Niederberger; Eva E Waltl; Renate Fuchs
Journal:  Protoplasma       Date:  2015-12-03       Impact factor: 3.356

Review 3.  Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.

Authors:  Katherine L Gill; Krishna K Machavaram; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

4.  FcRn is not the receptor mediating the transfer of serum IgG to colostrum in pigs.

Authors:  Cuncun Ke; Yonghe Ma; Dengke Pan; Zihui Wan; Tao Feng; Dawei Yu; Xiaojuan Liu; Haitao Wang; Minjie Du; Linhua Huang; Yifu Zhang; Lijuan Du; Xifeng Wang; Kongpan Li; Di Yu; Ming Zhang; Jinwei Huang; Junwei Qu; Liming Ren; Yanzhong Hu; Gengsheng Cao; Xiaoxiang Hu; Sen Wu; Haitang Han; Yaofeng Zhao
Journal:  Immunology       Date:  2021-04-15       Impact factor: 7.215

5.  Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis.

Authors:  Pamela J Hornby; Philip R Cooper; Connie Kliwinski; Edwin Ragwan; John R Mabus; Benjamin Harman; Suzanne Thompson; Amanda L Kauffman; Zhengyin Yan; Susan H Tam; Haimanti Dorai; Gordon D Powers; Jill Giles-Komar
Journal:  Pharm Res       Date:  2013-09-26       Impact factor: 4.200

6.  The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups.

Authors:  Philip R Cooper; Connie M Kliwinski; Robert A Perkinson; Edwin Ragwan; John R Mabus; Gordon D Powers; Haimanti Dorai; Jill Giles-Komar; Pamela J Hornby
Journal:  Front Pharmacol       Date:  2014-10-07       Impact factor: 5.810

7.  FcRn binding is not sufficient for achieving systemic therapeutic levels of immunoglobulin G after oral delivery of enteric-coated capsules in cynomolgus macaques.

Authors:  Salman Muzammil; John R Mabus; Philip R Cooper; Randall J Brezski; Courtney B Bement; Rob Perkinson; Norman D Huebert; Suzanne Thompson; Dalia Levine; Connie Kliwinski; Dino Bradley; Pamela J Hornby
Journal:  Pharmacol Res Perspect       Date:  2016-04-25

Review 8.  Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges.

Authors:  Kathryn Chapman; Akosua Adjei; Paul Baldrick; Antonio da Silva; Karen De Smet; Richard DiCicco; Seung Suh Hong; David Jones; Michael W Leach; James McBlane; Ian Ragan; Praveen Reddy; Donald I H Stewart; Amanda Suitters; Jennifer Sims
Journal:  MAbs       Date:  2016       Impact factor: 5.857

9.  Maturation of the Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression.

Authors:  Ester Arévalo Sureda; Björn Weström; Stefan G Pierzynowski; Olena Prykhodko
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 10.  Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.

Authors:  Federica Riccardo; Aline Réal; Claudia Voena; Roberto Chiarle; Federica Cavallo; Giuseppina Barutello
Journal:  Vaccines (Basel)       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.